Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Sernova Corp. / Key word(s): Study/Study results08.03.2023 / 13:05 CET/CESTThe issuer is solely responsible for the content of this announcement. Third patient now implanted with higher capacity, 10-chamber Cell Pouch Company anticipates first interim data from second cohort in Q4, 2023 LONDON, Ontario...
Issuer: Sernova Corp. / Key word(s): Study results30.01.2023 / 13:35 CET/CESTThe issuer is solely responsible for the content of this announcement. Preclinical proof of concept study demonstrates that thyroid auto-transplantation into the Cell Pouch can restore thyroid hormone production following removal of the thy...
First iPSC-derived commercially viable off-the-shelf islet combination product is advancing towards regulatory filing in 2024 for anticipated clinical...
10.01.2023 - Issuer: Sernova Corp. / Key word(s): Study results/Study Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes 10.01.2023 / 13:05 CET/CEST The ... Seite 1
Issuer: Sernova Corp. / Key word(s): Study results/Study10.01.2023 / 13:05 CET/CESTThe issuer is solely responsible for the content of this announcement.Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes Fi...